Merck & Co Inc

NYSE: MRK
$100.63
+$1.45 (+1.5%)
Real Time Data Delayed 15 Min.

MRK Articles

Apple survived a bloody week in the markets to return as the best-performing Dow Jones industrial stock for the year to date.
The top analyst upgrades, downgrades and initiations seen on Thursday included Abercrombie & Fitch, CME, Costco, DowDuPont, Gap, HCA, Herbalife, Merck, PayPal and Urban Outfitters.
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the remainder of October.
These five well-known stocks may be laggards but they look like they have solid upside potential, and all can help add alpha to portfolios.
Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of October.
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Nike's risky new ad campaign featuring NFL player Colin Kaepernick has paid off in higher sales and increased attention from analysts who have raised ratings and price targets and said lots of nice...
Apple, IBM, Merck, and Travelers buoyed the Dow index on Thursday.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Apple held on to its position as the best performing Dow stock for the year to date last week. Next Wednesday the company will introduce new iPhones and other products to the Apple faithful.
Boeing, Visa, Merck, and Verizon posted large enough gains to keep the Dow in the green Thursday.
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Nike stock added more than 3% to its share price last week, leading the company to wrestle away from Apple the position as the best performing Dow stock of 2018.
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.